Last reviewed · How we verify

NCT06077435

Comparative Analysis of AI Software for Enhanced Polyp Detection and Diagnosis

Recruiting now NA Last updated 24 November 2025
What this trial tests

NA trial testing AI in Colonic Polyp in 915 participants. Currently enrolling.

Timeline
1 March 2023
Primary endpoint
1 March 2026
1 June 2026

Quick facts

Lead sponsorSahlgrenska University Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment915
Start date1 March 2023
Primary completion1 March 2026
Estimated completion1 June 2026
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Sahlgrenska University Hospital

Who can join

Adults 50 to 90, any sex, with Colonic Polyp or Colon Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose \& Research Questions The purpose of this study is to evaluate whether artificial intelligence (AI) improves the detection of polyps and whether the system can classify the type and severity of detected changes. The investigators will also assess if there are any differences between the various AI systems and whether the polyps that may be missed are benign or malignant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of AI

Trials testing the same drug.

Other recruiting trials for Colonic Polyp

Currently open trials in the same condition.

Other Sahlgrenska University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06077435.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing